Tissue- and sex-specific regulation of CYP19A1 expression in the Atlantic croaker (Micropogonias undulatus).
To better define the tissue- and sex-specific roles of aromatase in fishes, we have isolated a CYP19A1 cDNA sequence from a well-developed model of teleost reproduction, the Atlantic croaker (Micropogonias undulatus). This cDNA encodes a protein which has high identity (57-90%) to known CYP19A1 proteins and segregates with teleost CYP19A1 proteins in molecular phylogenetic analysis. In both sexes, the gene encoding Atlantic croaker CYP19A1 is expressed primarily in gonadal tissue, but also in the brain and other tissues at much lower levels, as determined relative to ribosomal 18S RNA expression by real-time quantitative RT-PCR. In females, the highest levels of CYP19A1 mRNA are found in the developing ovary compared to spawning, regressing and resting ovaries. In contrast, testicular CYP19A1 expression is lowest in developing testes and increases in spawning and regressing testes, although there were no statistically significant differences between stages. Brain CYP19A1 mRNA levels are lower in animals with developing gonads compared to spawning fish. In vitro treatment with human chorionic gonadotropin (10 IU/ml) for 6 or 24h increases CYP19A1 mRNA approximately 16- and 43-fold, respectively, in isolated Atlantic croaker ovarian follicles, but has no effect on CYP19A1 mRNA in testicular or brain minces. Six hour in vitro treatment with sex steroids (estradiol, testosterone or 17,20 beta,21-trihydroxy-4-pregnen-3-one; 290 nM) does not alter CYP19A1 mRNA in ovary, testis or brain. The regulation of CYP19A1 in the Atlantic croaker therefore differs in a tissue- and sex-specific manner.
Nunez
B Scott
BS
The University of Texas Marine Science Institute, Port Aransas, TX 78373, USA. nunez@utmsi.utexas.edu
Applebaum
Scott L
SL
D000595:Amino Acid Sequence; D000818:Animals; D001141:Aromatase / Q000235:genetics* / Q000378:metabolism; D001921:Brain / Q000502:physiology; D006063:Chorionic Gonadotropin / Q000494:pharmacology; D018076:DNA, Complementary; D004958:Estradiol / Q000494:pharmacology; D005260:Female; D018507:Gene Expression Regulation, Developmental / Q000187:drug effects / Q000502:physiology; D015971:Gene Expression Regulation, Enzymologic / Q000187:drug effects / Q000502:physiology; D006908:Hydroxyprogesterones / Q000494:pharmacology; D008297:Male; D008969:Molecular Sequence Data; D009928:Organ Specificity; D010053:Ovary / Q000254:growth & development / Q000502:physiology*; D010473:Perciformes / Q000235:genetics / Q000502:physiology*; D010802:Phylogeny; D012333:RNA, Messenger / Q000378:metabolism; D012098:Reproduction / Q000502:physiology; D012737:Sex Factors; D013737:Testis / Q000254:growth & development / Q000502:physiology*; D013739:Testosterone / Q000494:pharmacology
D006063:Chorionic Gonadotropin; D018076:DNA, Complementary; D006908:Hydroxyprogesterones; D012333:RNA, Messenger; C007433:17,20-dihydroxy-4-pregnen-3-one; D013739:Testosterone; D004958:Estradiol; D001141:Aromatase